These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33106640)

  • 21. Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy.
    Li Q; Teng Z; Tao J; Shi W; Yang G; Zhang Y; Su X; Chen L; Xiu W; Yuwen L; Dong H; Mou Y
    Small; 2022 Aug; 18(32):e2201108. PubMed ID: 35734820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer.
    Zhou L; Hou B; Wang D; Sun F; Song R; Shao Q; Wang H; Yu H; Li Y
    Nano Lett; 2020 Jun; 20(6):4393-4402. PubMed ID: 32459969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.
    Qiu F; Becker KW; Knight FC; Baljon JJ; Sevimli S; Shae D; Gilchuk P; Joyce S; Wilson JT
    Biomaterials; 2018 Nov; 182():82-91. PubMed ID: 30107272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication.
    Maynard SK; Marshall JD; MacGill RS; Yu L; Cann JA; Cheng LI; McCarthy MP; Cayatte C; Robbins SH
    BMC Cancer; 2019 Jun; 19(1):540. PubMed ID: 31170937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo.
    Luo Z; Wang C; Yi H; Li P; Pan H; Liu L; Cai L; Ma Y
    Biomaterials; 2015 Jan; 38():50-60. PubMed ID: 25457983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy.
    Xiong X; Zhao J; Pan J; Liu C; Guo X; Zhou S
    Nano Lett; 2021 Oct; 21(19):8418-8425. PubMed ID: 34546061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.
    Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X
    Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-degradable poly(β-amino ester)s promote endosomal escape of antigen and agonist.
    Liu H; Hu Z; Chen H; Yan Y; Le Z; Wei C; Cao W; Chen T; Chen Y; Liu L
    J Control Release; 2022 May; 345():91-100. PubMed ID: 35259460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive polysaccharide-based pH-sensitive polymers for cytoplasmic delivery of antigen and activation of antigen-specific immunity.
    Yuba E; Yamaguchi A; Yoshizaki Y; Harada A; Kono K
    Biomaterials; 2017 Mar; 120():32-45. PubMed ID: 28027502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel self-assembled epitope peptide nanoemulsion vaccine targeting nasal mucosal epithelial cell for reinvigorating CD8
    Yang Y; Ge S; Song Z; Zhao A; Zhao L; Hu Z; Cai D; Zhang Z; Peng L; Lu D; Luo P; Zhang W; Sun H; Zou Q; Zeng H
    Int J Biol Macromol; 2021 Jul; 183():1891-1902. PubMed ID: 34052270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy.
    Peng J; Chen F; Liu Y; Zhang F; Cao L; You Q; Yang D; Chang Z; Ge M; Li L; Wang Z; Mei Q; Shao D; Chen M; Dong WF
    Theranostics; 2022; 12(4):1756-1768. PubMed ID: 35198071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.
    Luo M; Liu Z; Zhang X; Han C; Samandi LZ; Dong C; Sumer BD; Lea J; Fu YX; Gao J
    J Control Release; 2019 Apr; 300():154-160. PubMed ID: 30844475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.
    Jemon K; Young V; Wilson M; McKee S; Ward V; Baird M; Young S; Hibma M
    PLoS One; 2013; 8(6):e66866. PubMed ID: 23799135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation.
    Kotecha MT; Afghan RK; Vasilikopoulou E; Wilson E; Marsh P; Kast WM; Davies DH; Caparros-Wanderley W
    Vaccine; 2003 Jun; 21(19-20):2506-15. PubMed ID: 12744885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twin-screw extruded lipid implants containing TRP2 peptide for tumour therapy.
    Even MP; Bobbala S; Gibson B; Hook S; Winter G; Engert J
    Eur J Pharm Biopharm; 2017 May; 114():79-87. PubMed ID: 28104440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine.
    Liu D; Deng B; Liu Z; Ma B; Leng X; Kong D; Ji T; Liu L
    Nano Lett; 2021 May; 21(9):3965-3973. PubMed ID: 33886338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.